Advertisement
Research Article

Expression of the Multiple Sclerosis-Associated MHC Class II Allele HLA-DRB1*1501 Is Regulated by Vitamin D

  • Sreeram V. Ramagopalan equal contributor,

    equal contributor Contributed equally to this work with: Sreeram V. Ramagopalan, Narelle J. Maugeri

    Affiliations: Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom, Department of Clinical Neurology, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom

    X
  • Narelle J. Maugeri equal contributor,

    equal contributor Contributed equally to this work with: Sreeram V. Ramagopalan, Narelle J. Maugeri

    Affiliation: Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom

    X
  • Lahiru Handunnetthi,

    Affiliations: Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom, Department of Clinical Neurology, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom

    X
  • Matthew R. Lincoln,

    Affiliations: Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom, Department of Clinical Neurology, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom

    X
  • Sarah-Michelle Orton,

    Affiliations: Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom, Department of Clinical Neurology, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom

    X
  • David A. Dyment,

    Affiliations: Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom, Department of Clinical Neurology, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom

    X
  • Gabriele C. DeLuca,

    Affiliations: Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom, Department of Clinical Neurology, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom

    X
  • Blanca M. Herrera,

    Affiliations: Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom, Department of Clinical Neurology, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom

    X
  • Michael J. Chao,

    Affiliations: Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom, Department of Clinical Neurology, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom

    X
  • A. Dessa Sadovnick,

    Affiliations: Department of Medical Genetics, Division of Neurology, University of British Columbia, UBC Hospital, Vancouver, British Columbia, Canada, Faculty of Medicine, Division of Neurology, University of British Columbia, UBC Hospital, Vancouver, British Columbia, Canada

    X
  • George C. Ebers mail,

    george.ebers@clneuro.ox.ac.uk (GCE); julian@well.ox.ac.uk (JCK)

    Affiliations: Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom, Department of Clinical Neurology, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom

    X
  • Julian C. Knight mail

    george.ebers@clneuro.ox.ac.uk (GCE); julian@well.ox.ac.uk (JCK)

    Affiliation: Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom

    X
  • Published: February 06, 2009
  • DOI: 10.1371/journal.pgen.1000369

Reader Comments (6)

Post a new comment on this article

Press Coverage

Posted by sreeramr on 10 Feb 2009 at 13:22 GMT

We are just writing to make the readers of PLoS Genetics aware that there was an embargo breach in press coverage of this paper without our knowledge or permission. The Times of London, without our approval, published an article which we feel overstated the significance of this study.
We welcome comments from the PLoS Genetics readership about the actual results we obtained.

Sreeram Ramagopalan
Julian Knight
George Ebers
on behalf of the Canadian Collaborative Study Group